IL134111A0 - Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation - Google Patents
Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparationInfo
- Publication number
- IL134111A0 IL134111A0 IL13411198A IL13411198A IL134111A0 IL 134111 A0 IL134111 A0 IL 134111A0 IL 13411198 A IL13411198 A IL 13411198A IL 13411198 A IL13411198 A IL 13411198A IL 134111 A0 IL134111 A0 IL 134111A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- preparation
- compositions containing
- anovel
- triazolo
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- GIIGHSIIKVOWKZ-UHFFFAOYSA-N 2h-triazolo[4,5-d]pyrimidine Chemical class N1=CN=CC2=NNN=C21 GIIGHSIIKVOWKZ-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 150000003230 pyrimidines Chemical class 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702774A SE9702774D0 (sv) | 1997-07-22 | 1997-07-22 | Novel compounds |
| PCT/SE1998/001394 WO1999005144A1 (en) | 1997-07-22 | 1998-07-15 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL134111A0 true IL134111A0 (en) | 2001-04-30 |
Family
ID=20407805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13411198A IL134111A0 (en) | 1997-07-22 | 1998-07-15 | Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6166022A (enExample) |
| EP (1) | EP0998475B1 (enExample) |
| JP (1) | JP2001510843A (enExample) |
| KR (1) | KR20010022084A (enExample) |
| CN (1) | CN1270591A (enExample) |
| AT (1) | ATE216390T1 (enExample) |
| AU (1) | AU8370798A (enExample) |
| BR (1) | BR9811028A (enExample) |
| CA (1) | CA2296426A1 (enExample) |
| DE (1) | DE69804966T2 (enExample) |
| EE (1) | EE200000048A (enExample) |
| HU (1) | HUP0003826A3 (enExample) |
| ID (1) | ID25856A (enExample) |
| IL (1) | IL134111A0 (enExample) |
| IS (1) | IS5352A (enExample) |
| NO (1) | NO20000313L (enExample) |
| PL (1) | PL338181A1 (enExample) |
| SE (1) | SE9702774D0 (enExample) |
| SK (1) | SK188299A3 (enExample) |
| TR (1) | TR200000152T2 (enExample) |
| WO (1) | WO1999005144A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9702773D0 (sv) * | 1997-07-22 | 1997-07-22 | Astra Pharma Prod | Novel compounds |
| US6369064B1 (en) * | 1998-02-17 | 2002-04-09 | Astrazeneca Ab | Triazolo(4,5-d)pyrimidine compounds |
| CA2380656A1 (en) | 1999-09-09 | 2001-03-15 | Nadine Derrien | Substituted cyclopentenes, their preparation and their use for chiral scaffolds |
| SE9904129D0 (sv) * | 1999-11-15 | 1999-11-15 | Astra Pharma Prod | Novel compounds |
| US7115585B2 (en) * | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
| US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US6897201B2 (en) | 2000-08-21 | 2005-05-24 | Inspire Pharmaceuticals, Inc. | Compositions and methods for the treatment of glaucoma or ocular hypertension |
| AR039558A1 (es) * | 2000-08-21 | 2005-02-23 | Inspire Pharmaceuticals Inc | Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular |
| US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7435724B2 (en) * | 2002-02-27 | 2008-10-14 | Inspire Pharmaceutical, Inc. | Degradation-resistant mononucleoside phosphate compounds |
| CN1863789B (zh) | 2003-10-03 | 2010-06-09 | 博尔托拉制药公司 | 取代的异喹啉酮 |
| CA2540214A1 (en) | 2003-10-03 | 2005-04-14 | Portola Pharmaceuticals, Inc. | 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| EP1685135B1 (en) | 2003-10-21 | 2010-05-26 | Inspire Pharmaceuticals, Inc. | TETRAHYDRO-FURO[3,4-d]DIOXOLE COMPOUNDS AND COMPOSITIONS AND METHOD FOR INHIBITING PLATELET AGGREGATION |
| US7335648B2 (en) | 2003-10-21 | 2008-02-26 | Inspire Pharmaceuticals, Inc. | Non-nucleotide composition and method for inhibiting platelet aggregation |
| US7749981B2 (en) | 2003-10-21 | 2010-07-06 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
| US7504497B2 (en) | 2003-10-21 | 2009-03-17 | Inspire Pharmaceuticals, Inc. | Orally bioavailable compounds and methods for inhibiting platelet aggregation |
| KR20070064356A (ko) | 2004-09-29 | 2007-06-20 | 포톨라 파마슈티컬스, 인코포레이티드 | 치환된 2ｈ-1,3-벤족사진-4(3ｈ)온 |
| US7932376B2 (en) | 2005-05-05 | 2011-04-26 | Inspire Pharmaceuticals, Inc. | Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation |
| JPWO2007020935A1 (ja) * | 2005-08-17 | 2009-02-26 | 小野薬品工業株式会社 | Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤 |
| WO2007056219A2 (en) | 2005-11-03 | 2007-05-18 | Portola Pharmaceuticals, Inc. | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
| JP2010508350A (ja) | 2006-10-31 | 2010-03-18 | ヤンセン ファーマシューティカ エヌ．ベー． | Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体 |
| WO2011133871A2 (en) * | 2010-04-22 | 2011-10-27 | Alnylam Pharmaceuticals, Inc. | 5'-end derivatives |
| EP2576553A4 (en) * | 2010-05-27 | 2013-11-20 | Reddys Lab Ltd Dr | EXTREMELY SELECTIVE ASYMMETRIC HYDROFORMYLATION OF (+) OR (-) - LACTAM (1S, 4R) - OR (1R, 4S) -2-AZABICYCLO [2.2.1] HEPT-5-EN-3-ONE |
| US9458244B2 (en) | 2012-12-28 | 2016-10-04 | Abbvie Inc. | Single chain multivalent binding protein compositions and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4742064A (en) * | 1985-09-10 | 1988-05-03 | Regents Of The University Of Minnesota | Antiviral carbocyclic analogs of xylofuranosylpurines |
| GB8826205D0 (en) * | 1988-11-09 | 1988-12-14 | Wellcome Found | Heterocyclic compounds |
| WO1994018215A1 (en) * | 1993-02-03 | 1994-08-18 | Gensia, Inc. | Adenosine kinase inhibitors comprising lyxofuranosyl derivatives |
| TR199800019T1 (xx) * | 1995-07-11 | 1998-05-21 | Astra Pharmaceuticals Limited | Trombosit topaklanmas�n� �nleyici yeni maddeler. |
-
1997
- 1997-07-22 SE SE9702774A patent/SE9702774D0/xx unknown
-
1998
- 1998-07-15 TR TR2000/00152T patent/TR200000152T2/xx unknown
- 1998-07-15 EP EP98934108A patent/EP0998475B1/en not_active Expired - Lifetime
- 1998-07-15 KR KR1020007000653A patent/KR20010022084A/ko not_active Withdrawn
- 1998-07-15 CA CA002296426A patent/CA2296426A1/en not_active Abandoned
- 1998-07-15 IL IL13411198A patent/IL134111A0/xx unknown
- 1998-07-15 ID IDW20000145D patent/ID25856A/id unknown
- 1998-07-15 HU HU0003826A patent/HUP0003826A3/hu unknown
- 1998-07-15 AT AT98934108T patent/ATE216390T1/de active
- 1998-07-15 EE EEP200000048A patent/EE200000048A/xx unknown
- 1998-07-15 JP JP2000504140A patent/JP2001510843A/ja active Pending
- 1998-07-15 CN CN98809157A patent/CN1270591A/zh active Pending
- 1998-07-15 SK SK1882-99A patent/SK188299A3/sk unknown
- 1998-07-15 PL PL98338181A patent/PL338181A1/xx not_active Application Discontinuation
- 1998-07-15 AU AU83707/98A patent/AU8370798A/en not_active Abandoned
- 1998-07-15 WO PCT/SE1998/001394 patent/WO1999005144A1/en not_active Ceased
- 1998-07-15 DE DE69804966T patent/DE69804966T2/de not_active Expired - Fee Related
- 1998-07-15 BR BR9811028-4A patent/BR9811028A/pt not_active IP Right Cessation
- 1998-07-15 US US09/155,567 patent/US6166022A/en not_active Expired - Fee Related
-
2000
- 2000-01-19 IS IS5352A patent/IS5352A/is unknown
- 2000-01-21 NO NO20000313A patent/NO20000313L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69804966T2 (de) | 2002-11-07 |
| NO20000313L (no) | 2000-03-22 |
| EP0998475B1 (en) | 2002-04-17 |
| US6166022A (en) | 2000-12-26 |
| CA2296426A1 (en) | 1999-02-04 |
| CN1270591A (zh) | 2000-10-18 |
| EP0998475A1 (en) | 2000-05-10 |
| NO20000313D0 (no) | 2000-01-21 |
| ID25856A (id) | 2000-11-09 |
| EE200000048A (et) | 2000-10-16 |
| HUP0003826A3 (en) | 2001-11-28 |
| KR20010022084A (ko) | 2001-03-15 |
| JP2001510843A (ja) | 2001-08-07 |
| SK188299A3 (en) | 2000-08-14 |
| DE69804966D1 (de) | 2002-05-23 |
| AU8370798A (en) | 1999-02-16 |
| HUP0003826A2 (hu) | 2001-04-28 |
| ATE216390T1 (de) | 2002-05-15 |
| TR200000152T2 (tr) | 2000-07-21 |
| PL338181A1 (en) | 2000-10-09 |
| BR9811028A (pt) | 2000-08-01 |
| WO1999005144A1 (en) | 1999-02-04 |
| IS5352A (is) | 2000-01-19 |
| SE9702774D0 (sv) | 1997-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL134111A0 (en) | Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation | |
| IL134112A0 (en) | Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation | |
| IL132153A0 (en) | Novel compounds | |
| IL122855A0 (en) | 7H-pyrrolo [2,3-d] pyrimidine derivatives their preparation and pharmaceutical compositions containing them | |
| UA66801C2 (uk) | Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів | |
| MY121867A (en) | Novel triazolo(4,5-d)pyrimidine compounds. | |
| PL340836A1 (en) | Novel compounds | |
| HUT70505A (en) | Pyrrolo[2,3-d]pyrimidine derivatives, pharmaceutical compositions containing them and process for preparing them | |
| CA2316921A1 (en) | Aryl fused azapolycyclic compounds | |
| AU2002305143A1 (en) | Pyrazolo'1,5-a!pyridine derivatives | |
| IL130538A0 (en) | Pyrrolo ¬3,4-d¾pyrimidinone derivatives and their use as medicaments | |
| GEP20033081B (en) | Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas | |
| SE9702563D0 (sv) | Compounds | |
| MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
| ATE251162T1 (de) | Triazolo(4,5-d)pyrimidin-verbindungen | |
| AU2002214467A1 (en) | Novel compounds | |
| CA2235967A1 (en) | Diarylethylene metallocene derivatives, their processes of preparation and pharmaceutical compositions containing said derivatives |